Tag: subcutaneous

BMJ journal deems opioid dependency implant more favourable than tablets

by Anna Smith | Mar 27, 2020 | News | 0

While the opioid epidemic in the USA is well documented, Europe also has an estimated 1.3 million high-risk opioid users.

Subcutaneous Entyvio hits Crohn’s primary endpoint, misses secondary

by Anna Smith | Feb 17, 2020 | News | 0

If approved, the drug could have huge benefits for patients as they could self-administer their therapy from home.

EMA accepts Takeda application for subcutaneous Entyvio

by Anna Smith | Apr 3, 2019 | News | 0

The company proposes to make it available in both pre-filled syringe and pen options.

Teva’s subcutaneous asthma drug fails in PhIII

by Selina McKee | Jan 23, 2018 | News | 0

Teva’s quest to expand approval of its respiratory drug Cinquair/Cinqaero with a new mode of delivery has hit a snag, after two late-stage studies failed to hit their targets.

Roche bags EU nod for subcutaneous MabThera shot

by Selina McKee | May 31, 2016 | News | 0

The European Commission has approved a subcutaneous formulation of Roche’s MabThera for chronic lymphocytic leukaemia, saving time and easing the treatment burden compared with drug’s intravenous form, says the drugmaker.